Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06271044
NA
a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
Sponsor: Helsinki University Central Hospital
View on ClinicalTrials.gov
Summary
To study if its is safe to reduce the amount of postoperative treatments in those patients, who have been operated on because of a low-risk intrathyroidal papillary thyroid cancer with diameter of 11-20mm, and in whom postoperative thyroglobulin levels are of low level.
Official title: Reducing Radioiodine Treatment in Low Risk Papillary Thyroid Cancer
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
61
Start Date
2014-10
Completion Date
2027-12-31
Last Updated
2024-02-21
Healthy Volunteers
No
Interventions
OTHER
With radioiodine treatment
Postoperative radioiodine not given
PROCEDURE
With postoperative radioiodine treatment
Postoperative radioiodine given